-
such as Scientific Communications, Regulatory Affairs, Health Economics and Outcomes Research, Biostatistics, Professional Development, or the Commercial Organization through longitudinal projects
-
drug applications and international marketing authorization applications Collaborate with Clinical, Global Patient Safety and Risk Management, Biostatistics, and Medical teams in US and EU to achieve
-
, Biostatistics, Professional Development, or the Commercial Organization through longitudinal projects. The fellow will also have the opportunity to attend Medical Congresses. Rotations may be extended
-
drug applications and international marketing authorization applications Collaborate with Clinical, Global Patient Safety and Risk Management, Biostatistics, and Medical teams in US and EU to achieve
-
applications · Collaborate with Clinical, Global Patient Safety and Risk Management, Biostatistics, and Medical teams in US and EU to achieve regulatory milestones · Participate in cross-functional
-
disseminating results via conferences, talks, and first-author manuscripts. Expertise in any or all of these skills is not required. Qualifications: Applicants should have a PhD degree (or expected by September 1
-
U.S. PhD degree candidates Additional Information Applicants should submit the following application materials by the priority deadline of October 31, 2025: 1. Curriculum vitae (CV), uploaded 2
-
application materials by the priority deadline of October 31, 2025: 1. Curriculum vitae (CV), uploaded 2. Unofficial PharmD/PhD transcripts, uploaded 3. Cover letter, uploaded Three formal letters
-
application materials by the priority deadline of October 31, 2025: 1. Curriculum vitae (CV), uploaded 2. Unofficial PharmD/PhD transcripts, uploaded 3. Cover letter, uploaded Three formal letters
-
U.S. PhD degree candidates Additional Information Applicants should submit the following application materials by the priority deadline of October 31, 2025: 1. Curriculum vitae (CV), uploaded 2